May 4, 2017
Karo Pharma reaches second milestone from collaboration with Pfizer
Karo Pharma has reached a second milestone from its collaboration with Pfizer on the RORgamma project amounting to $2 million.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
May 4, 2017
argnex half through myasthenia gravis drug study
argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, has recruited 50% of the myasthenia gravis (MG) patients in the Phase 2 proof-of-concept study of ARGX-113.
May 4, 2017
Mereo BioPharma starts Phase 2 study of rare bone disease drug
Mereo BioPharma Group, a clinical stage, biopharmaceutical company focused on rare and specialty diseases, has initiated a potentially pivotal Phase 2b clinical study of BPS-804 for the treatment of the orphan disease, osteogenesis imperfecta (OI) (brittle bone disease), the ASTEROID study.
May 4, 2017
CTI BioPharma reports $19.8M loss
CTI BioPharma has reported net loss of $19.8 million for the first quarter of 2017. The loss is decrease compared to the profit of $3.3 million for the same period in 2016.
May 4, 2017
Sobi welcomes new CEO
Swedish Orphan Biovitrum (Sobi) has appointed Guido Oelkers as President and Chief Executive Officer effective as of 22 May 2017, succeeding Geoffrey McDonough.
May 3, 2017
Novo Nordisk reports 10% profit increase for Q1 2017
Novo Nordisk has reported profit of €1.4 billion for the first quarter of 2017, which is increase of 10%.
May 3, 2017
Sobi with new haemophilia research office in Greece
Swedish Orphan Biovitrum (Sobi) will open a new office in Athens, Greece.
April 28, 2017
US FDA to review biologics license application resubmission for Kevzara
Sanofi and Regeneron Pharmaceuticals have resubmitted their Biologics License Application for Kevzara, which is an investigational human monoclonal antibody to be used for treatment of rheumatoid arthritis (RA) with adult patients.
April 27, 2017
AstraZeneca hopes to escape drug sales trough in second half
AstraZeneca, struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter of falling drug sales on Thursday as it awaits pivotal clinical trial data that may revive its fortunes.
April 27, 2017
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company’s drugs, and also suspended insurance coverage for some of its drugs.